Skip to main content
Erschienen in:

01.03.2018 | Science in CEE countries

Etidronic acid and its calcium-comprising complexes in the treatment of experimental osteoporosis in estrogen-deficient rats

verfasst von: V. V. Povoroznyuk, N. V. Grygorieva, V. I. Pekhnyo, H. Resch, O. M. Kozachkova, N. V. Tsaryk

Erschienen in: Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Aim

The aim of this study was to investigate the composition, stability, and biological activity of the complexes formed in solution upon interaction of calcium (Ca) ions with etidronic acid (EA), and to compare their effects on bone mineral density (BMD) in estrogen-deficient rats with osteoporosis.

Materials and methods

The study was conducted on 40 female Wistar rats. Osteoporosis was modeled by bilateral oophorectomy and therapy was started 4 months after surgery. Four groups were under study: the first group did not receive any osteoporotic treatment, only supplementation of Ca/vitamin D (D) in their diet. The second group received a single parenteral dose of EA with Ca/D supplementation. The third group received a Ca complex of EA (Ca-EA) without additional use of Ca/D. The fourth group received Ca-EA with Ca/D. Bone parameters (BMD and bone mineral content [BMC] in spine and total body) were measured by X‑ray densitometry using Prodigy (GE Medical systems, Model 8743, 2005; USA; program “Experimental animals”) thrice (before treatment, after 1 and 3 months of follow-up).

Results

Therapy with EA and Ca/D showed significant differences in total body BMD (tbBMD) only after 3 months. We established reliable changes in spine BMD (sBMD) and tbBMD after 1 and 3 months of treatment in group 3 rats: administration of Ca-EA with Ca/D had positive effects on sBMD at 1 and 3 months, and on tbBMD after 3 months. We did not establish any significant changes between sBMD and tbBMD after 1 and 3 months of therapy dependent on additional Ca/D supplementation (groups 3 and 4).

Conclusion

We showed a positive effect of the studied Ca-EA complexes on the BMD and BMC indices, with or without additional supplementation of Ca/D. More explicit dynamics of indices were observed in the group of animals treated with Ca-EA without additional Ca/D after 1 and 3 months of follow-up.
Literatur
1.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J‑Y, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57. https://doi.org/10.1007/s00198-012-2074-y CrossRefPubMed Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J‑Y, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57. https://​doi.​org/​10.​1007/​s00198-012-2074-y CrossRefPubMed
2.
Zurück zum Zitat Camacho PM, Peak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2016—Executive Summary. Endocr Pract 22(9):1111–1118. https://doi.org/10.4158/EP161435.ESGL CrossRefPubMed Camacho PM, Peak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2016—Executive Summary. Endocr Pract 22(9):1111–1118. https://​doi.​org/​10.​4158/​EP161435.​ESGL CrossRefPubMed
3.
Zurück zum Zitat Povoroznyuk VV, Grygorieva NV, Orlyk TV et al (2014) Osteoporosis in the practice of internist doctor. Express, Kyiv (Russian) Povoroznyuk VV, Grygorieva NV, Orlyk TV et al (2014) Osteoporosis in the practice of internist doctor. Express, Kyiv (Russian)
11.
Zurück zum Zitat Council of Europe (1986) European convention for the protection of vertebrate animals used for experimental and other scientific purpose: Council of Europe 18.03.1986. Council of Europe, Strasbourg Council of Europe (1986) European convention for the protection of vertebrate animals used for experimental and other scientific purpose: Council of Europe 18.03.1986. Council of Europe, Strasbourg
12.
Zurück zum Zitat Povoroznyuk VV, Deduh NV, Grygorieva NV, Gopkalova IV (2012) Experimental osteoporosis. Express, Kyiv (Russian) Povoroznyuk VV, Deduh NV, Grygorieva NV, Gopkalova IV (2012) Experimental osteoporosis. Express, Kyiv (Russian)
13.
Zurück zum Zitat Afonin EG, Aleksandrov GG, Ilyinsky AL (2000) Diprotonated 1‑hydroxyethane-1,1-diphosphonate of calcium. Russ J Inorg Chem 45(6):961–966 Afonin EG, Aleksandrov GG, Ilyinsky AL (2000) Diprotonated 1‑hydroxyethane-1,1-diphosphonate of calcium. Russ J Inorg Chem 45(6):961–966
14.
Zurück zum Zitat Gómez-Alcántara MM, Cabeza A, Martínez-Lara M, Aranda MA, Suau R, Bhuvanesh N, Clearfield A (2004) Synthesis and characterization of a new bisphosphonic acid and several mEAl hybrids derivatives. Inorg Chem 43(17):5283–5293CrossRefPubMed Gómez-Alcántara MM, Cabeza A, Martínez-Lara M, Aranda MA, Suau R, Bhuvanesh N, Clearfield A (2004) Synthesis and characterization of a new bisphosphonic acid and several mEAl hybrids derivatives. Inorg Chem 43(17):5283–5293CrossRefPubMed
15.
Zurück zum Zitat De Colli M, Tortorella P, Marconi GD, Agamennone M, Campestre C, Tauro M, Cataldi A, Zara S (2016) In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover. Clin Oral Investig 20(8):2013–2021CrossRefPubMed De Colli M, Tortorella P, Marconi GD, Agamennone M, Campestre C, Tauro M, Cataldi A, Zara S (2016) In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover. Clin Oral Investig 20(8):2013–2021CrossRefPubMed
16.
Zurück zum Zitat Ferrer-Casal M, Li C, Galizzi M, Stortz CA, Szajnman SH, Docampo R, Moreno SNJ, Rodriguez JB (2014) New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase. Bioorg Med Chem 22(1):398–405CrossRefPubMed Ferrer-Casal M, Li C, Galizzi M, Stortz CA, Szajnman SH, Docampo R, Moreno SNJ, Rodriguez JB (2014) New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase. Bioorg Med Chem 22(1):398–405CrossRefPubMed
17.
Zurück zum Zitat Komisarenko SV, Sharykina NI, Lozynskyi MO, Lozynskyi MO, Karlova NP, Kudriavtseva IH, Kuzmenko IY, Borysevych AM, Yezerska LY (2001) Patent number UA 40714. Published 15.08.2001. Antitumor agent (mebiphon) Russian Komisarenko SV, Sharykina NI, Lozynskyi MO, Lozynskyi MO, Karlova NP, Kudriavtseva IH, Kuzmenko IY, Borysevych AM, Yezerska LY (2001) Patent number UA 40714. Published 15.08.2001. Antitumor agent (mebiphon) Russian
Metadaten
Titel
Etidronic acid and its calcium-comprising complexes in the treatment of experimental osteoporosis in estrogen-deficient rats
verfasst von
V. V. Povoroznyuk
N. V. Grygorieva
V. I. Pekhnyo
H. Resch
O. M. Kozachkova
N. V. Tsaryk
Publikationsdatum
01.03.2018
Verlag
Springer Vienna
Erschienen in
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen / Ausgabe 1/2018
Print ISSN: 2412-8260
Elektronische ISSN: 2412-8287
DOI
https://doi.org/10.1007/s41970-017-0018-x

Weitere Artikel der Ausgabe 1/2018

Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 1/2018 Zur Ausgabe

Mitteilungen des Magnesium- und Osteoporoseforums Bad Radkersburg

Mitteilungen des Magnesium- und Osteoporoseforums Bad Radkersburg

Editorial

Editorial

News-Screen Rheumatologie

News-Screen Rheumatologie